NRG
IDXX icon

Nemes Rush Group’s Idexx Laboratories IDXX Stock Holding History

Nemes Rush Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25K Hold
4
– – ﹤0.01% 728
2025
Q4 		$2.71K Buy
+4
New +$2.72K ﹤0.01% 692

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nemes Rush Group's IDXX Position: Q1 2026 in Review

Nemes Rush Group held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 4 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #728.

Nemes Rush Group first reported a position in IDXX in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.71K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Nemes Rush Group held 4 shares of Idexx Laboratories worth $2.25K as of Q1 2026.
  • Nemes Rush Group left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of Nemes Rush Group's portfolio in Q1 2026, its #728 holding.
  • Nemes Rush Group first reported a position in Idexx Laboratories in Q4 2025 and has held it in 2 quarters since.
  • Nemes Rush Group's Idexx Laboratories position peaked at $2.71K in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.